Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-02-20 @ 8:15 PM
Study NCT ID:
NCT03025256
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-03
First Post:
2017-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acral Lentiginous Melanoma | View |
| None | Central Nervous System Melanoma | View |
| None | Clinical Stage IV Cutaneous Melanoma AJCC v8 | View |
| None | Leptomeningeal Neoplasm | View |
| None | Melanocytoma | View |
| None | Metastatic Lung Non-Small Cell Carcinoma | View |
| None | Metastatic Melanoma | View |
| None | Metastatic Mucosal Melanoma | View |
| None | Metastatic Uveal Melanoma | View |
| None | Stage IV Lung Cancer AJCC v8 | View |
Keywords: